Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS
Phase 4
Completed
- Conditions
- Multiple SclerosisAutonomic Nervous System Dysfunction
- Interventions
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- Jochen Vehoff
- Target Recruit Count
- 33
- Registration Number
- NCT02048072
- Locations
- 🇨🇭
Cantonal Hospital St. Gallen, St. Gallen, SG, Switzerland
News
No news found